Literature DB >> 19342833

Inflammatory and neuroimmunomodulatory changes in acute cerebral ischemia.

David Brea1, Tomás Sobrino, Pedro Ramos-Cabrer, José Castillo.   

Abstract

Neuronal death produced by cerebral ischemia activates innate immunity by Toll-like receptors and triggers inflammatory response. This response is necessary to remove cell debris and to start regenerative process. However, inflammatory response could exacerbate cerebral damage and it is involved in secondary brain damage. Therefore, organisms have developed different mechanisms to regulate inflammatory response. An accurate balance between inflammation and anti-inflammation is necessary to assure the removal of cell debris and to avoid secondary cell damage. New therapeutic targets could be designed to obtain a correct modulation of the immune system and to reduce cerebral brain damage after cerebral ischemia. In this paper, we review the function of the immune system in cerebral ischemia, particularly inflammation and immunomodulation. (c) 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19342833     DOI: 10.1159/000200441

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  39 in total

1.  Scavenger receptor class-A has a central role in cerebral ischemia-reperfusion injury.

Authors:  Chen Lu; Fang Hua; Li Liu; Tuanzhu Ha; John Kalbfleisch; John Schweitzer; Jim Kelley; Race Kao; David Williams; Chuanfu Li
Journal:  J Cereb Blood Flow Metab       Date:  2010-04-28       Impact factor: 6.200

2.  MRI stem cell tracking for therapy in experimental cerebral ischemia.

Authors:  Pedro Ramos-Cabrer; Mathias Hoehn
Journal:  Transl Stroke Res       Date:  2011-10-27       Impact factor: 6.829

3.  Exon Array Biomarkers for the Differential Diagnosis of Schizophrenia and Bipolar Disorder.

Authors:  Marquis Philip Vawter; Robert Philibert; Brandi Rollins; Patricia L Ruppel; Terry W Osborn
Journal:  Mol Neuropsychiatry       Date:  2018-04-10

4.  Panax notoginseng saponins administration modulates pro- /anti-inflammatory factor expression and improves neurologic outcome following permanent MCAO in rats.

Authors:  Xiaowei Shi; Wenjing Yu; Lixing Liu; Wei Liu; Xiaomeng Zhang; Tiantian Yang; Limin Chai; Lixia Lou; Yonghong Gao; Lingqun Zhu
Journal:  Metab Brain Dis       Date:  2016-09-02       Impact factor: 3.584

5.  The breadth and type of systemic inflammation and the risk of adverse neurological outcomes in extremely low gestation newborns.

Authors:  Karl C K Kuban; T Michael O'Shea; Elizabeth N Allred; Raina N Fichorova; Tim Heeren; Nigel Paneth; Deborah Hirtz; Olaf Dammann; Alan Leviton
Journal:  Pediatr Neurol       Date:  2014-10-16       Impact factor: 3.372

6.  HMBG1 mediates ischemia-reperfusion injury by TRIF-adaptor independent Toll-like receptor 4 signaling.

Authors:  Qing-Wu Yang; Feng-Lin Lu; Yu Zhou; Lin Wang; Qi Zhong; Sen Lin; Jing Xiang; Jing-Cheng Li; Chuan-Qing Fang; Jing-Zhou Wang
Journal:  J Cereb Blood Flow Metab       Date:  2010-08-11       Impact factor: 6.200

7.  Cornel iridoid glycoside inhibits inflammation and apoptosis in brains of rats with focal cerebral ischemia.

Authors:  Bai-liu Ya; Chun-yang Li; Lan Zhang; Wen Wang; Lin Li
Journal:  Neurochem Res       Date:  2010-02-13       Impact factor: 3.996

8.  Anti-inflammatory and neuroprotective effects of sanguinarine following cerebral ischemia in rats.

Authors:  Qin Wang; Peng Dai; Han Bao; Ping Liang; Wei Wang; An Xing; Jianbin Sun
Journal:  Exp Ther Med       Date:  2016-12-02       Impact factor: 2.447

9.  Imaging of perfusion, angiogenesis, and tissue elasticity after stroke.

Authors:  Abraham Martín; Emilie Macé; Raphael Boisgard; Gabriel Montaldo; Benoit Thézé; Mickael Tanter; Bertrand Tavitian
Journal:  J Cereb Blood Flow Metab       Date:  2012-04-11       Impact factor: 6.200

10.  TLR4 polymorphisms affect stroke risk and inflammatory response in Chinese ischemic stroke patients.

Authors:  Lian Gu; Jingyan Huang; Baoyun Liang; Qing Chen; Juanjuan Xie; Junwei Yang; Yan Yan; Qianli Tang
Journal:  Neurol Sci       Date:  2017-10-26       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.